Gendaq

Gendaq Ltd. is a biopharmaceutical company built on pioneering research into transcription factors known as zinc-finger DNA-binding proteins.The company’s gene regulation technology enables the upregulation and downregulation of any gene in any eukaryotic cell and can be applied across multiple fields, including human therapeutics, gene therapy, disease diagnostics, and functional genomics.In 2001, Gendaq Ltd. was acquired by Sangamo BioSciences (NASDAQ: SGMO), a company listed on NASDAQ.